trending Market Intelligence /marketintelligence/en/news-insights/trending/z2-bIA3kKc6B92tdgLMiTg2 content esgSubNav
In This List

Insulet appoints 2 directors

Blog

Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion

Blog

Global M&A by the Numbers: Q2 2022

Blog

Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms

Blog

Infographic 2022 Top Tech Trends Shaping Corporations


Insulet appoints 2 directors

Insulet Corp. appointed Michael Minogue and James Mullen to its board of directors.

The company also said that Regina Sommer and Joseph Zakrzewski retired from the board.

Minogue is CEO, president and chairman of medical device manufacturer ABIOMED Inc.

Mullen is CEO of pharmaceutical contract development and manufacturing organization Patheon N.V., which is in the process of being acquired by Thermo Fisher Scientific Inc.